AI

Goldman Says Palantir’s AI Opportunity Just Got Bigger

Goldman sees more than another wave of AI spending Palantir Technologies (NASDAQ: PLTR) is approaching its record high again, but Goldman Sachs thinks the more important move may be happening inside the business. Goldman analyst Gabriela Borges upgraded Palantir from

TSMC Hits Record as AI Demand Drives 2027 Growth

TSMC does not need to pick the next AI winner Taiwan Semiconductor Manufacturing (NYSE: TSM) has already delivered one of the strongest semiconductor runs of the year. Shares are up nearly 40% in 2026, and the stock has recently pushed

Anthropic Is Pulling Ahead in the Enterprise AI Race

Anthropic found the part of AI companies will actually pay for OpenAI may have introduced generative AI to the mass market, but Anthropic is increasingly making the stronger case inside the enterprise. According to a leaked S-1 obtained by Reuters,

Akamai Lands $11.6 Billion Anthropic AI Cloud Deal

Akamai just landed the kind of contract that can change a company’s story Akamai Technologies (NASDAQ: AKAM) has spent years being known primarily for content delivery and cybersecurity. A new deal with Anthropic could force the market to look at

Meta’s $14 Billion AI Talent Bet Is Starting to Pay Off

Zuckerberg’s expensive AI reset is starting to make sense When Meta (NASDAQ: META) committed $14.3 billion to Scale AI in 2025 and brought founder Alexandr Wang into the company, the price immediately raised eyebrows. Meta was trying to close ground

AI Has a $68 Billion Data Center Problem

The AI boom is running into city hall The largest technology companies have committed hundreds of billions of dollars to AI infrastructure, but money does not guarantee that a data center gets built. Between April and June, 45 U.S. projects

AI Fears Are Fueling a Cybersecurity Stock Rally

AI’s latest scare created an unexpected winner The same warnings that rattled chipmakers this week have sent cybersecurity stocks in the opposite direction. CrowdStrike (NASDAQ: CRWD) is up roughly 14% since Monday, while Okta (NASDAQ: OKTA) has gained 10% and

Novo Nordisk Turns to AI to Speed Up Drug Development

Novo is already using AI where the payoff is easy to see The most interesting part of Novo Nordisk’s new partnership with Anthropic is not the promise that AI could one day help discover better medicines. Claude is already saving